SpeedWeed

JULY 6, 2021

Harvard Law School is planning to open the first US policy center focused on the legalization and regulation of psychedelics like psilocybin, MDMA, and LSD. . By analyzing social, legal, and political barriers to access in this context, we hope to advance the understanding of their potential impact as therapeutics.”.

Policy 52

Policy Law Research and Development Therapy 52

Cannabis Law Report

JUNE 14, 2022

Those values guide our joint efforts to change perceptions about psychedelic assisted therapies, raise awareness of the scientific advances and, ultimately, bring better health to European citizens. Ketamine is already registered for the treatment of depression and in 2023, the FDA might approve an MDMA assisted therapy for PTSD.

Access 52

Access Therapy Clinical Trials Treatment 52

Cannabis Law Report

APRIL 15, 2022

On Monday, a Maryland House of Delegates committee took up a Senate-passed bill to establish a state fund that could be used to provide “cost-free” access to psychedelics like psilocybin, MDMA , and ketamine to military veterans suffering from those all-too-common afflictions. The Beard Brothers site reports. Sarah Elfreth’s proposal (D).

Access 52

Access Therapy Legislation Policy 52

Cannabis Law Report

JULY 1, 2021

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School is engaged in a three-year initiative to examine the ethical, legal, and social implications of psychedelics research, commerce, and therapeutics. While psychedelic therapies make their way through the drug development pipeline, seven U.S.

Law 59

Law Policy Research and Development Clinical Trials 59

Cannabis Law Report

JANUARY 5, 2022

W hile this Review focuses on 2021, it’s difficult to contextualise the levels of psychedelic drug policy reform witnessed this year without appreciating the gravitas of events in late 2020. Beyond progress updates on these two landmark initiatives, 2021 saw a flurry of policy reform efforts across the world. Introduction.

Policy 52

Policy Therapy Banking Events 52

Cannabis Law Report

MARCH 3, 2020

In Indianapolis on January 29, a quiet, eager audience of nurses give their rapt attention to Jason Straw as he takes center stage at the 2020 ISNA Policy Conference. ISNA 2020 POLICY CONFERENCE AGENDA, Jason Straw- Cannabis Policy. ISNA 2020 POLICY CONFERENCE AGENDA, Jason Straw- Cannabis Policy. PURPOSE : .

Policy 105

Policy Research and Development Chronic Pain Cannabinoids 105

Veriheal

MARCH 20, 2023

Alternative medicine is becoming more widely acknowledged and practiced than ever before, opening the door for therapies like psychedelics to enter the world of mainstream healthcare. Psilocybin therapy is both studied and used by highly legitimate medical establishments. Ned Lamont signed a bill (HB 5506) to fund psychedelic therapy.

Clinical Trials 98

Clinical Trials Therapy Decriminalization Treatment 98

Cannabis Law Report

AUGUST 10, 2021

As psychedelic therapy trials approach FDA approval, researchers express the urgent need to ensure effectiveness and accessibility to communities of color. Madison Natarajan, MS. – August 5, 2021.

Clinical Trials 105

Clinical Trials Research and Development Therapy Treatment 105

Veriheal

JUNE 30, 2023

A study investigated psilocybin’s effect on alcohol addiction, the FDA outlined best practices for future psychedelic research, and the NCAA is inching toward cannabis policy change. Lastly, the guide lays out the complex DEA registration process researchers much navigate to gain access to plants like psilocybin.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

MMJ Recs

JANUARY 24, 2024

Today we’ll take a closer look at the Michigan Medical Marijuana Program, giving Michigan citizens all the info they need about accessing MMJ in the state. The state legalized medical marijuana in 2008, establishing a framework for patients to access cannabis for therapeutic purposes.

Programs 52

Programs Marijuana Access Chronic Pain 52

Cannabis Law Report

JANUARY 12, 2022

Today, Maya (Maya PBC) and the National Psychedelics Association (NPA) announced their partnership in support of the implementation of Oregon’s Measure 109, the first state-approved policy to allow the regulated use of psilocybin products in a facilitated setting.

Research and Development 52

Research and Development Therapy Safety Clinical Trials 52

MMJ Recs

MARCH 20, 2024

Through these specialized services, Maryland dispensaries play a crucial role in providing accessible and quality medical cannabis options to patients statewide. These expansions aim to increase patient access and address supply shortages experienced in the past.

Dispensary 52

Dispensary Programs Access Patients 52

Cannabis Law Report

SEPTEMBER 10, 2021

This exciting partnership between these innovative startups aims to advance patient access to psychedelic treatments in Europe, and improve the quality of the psychedelic medicines produced in Europe. We look forward to working closely with the Clerkenwell Health team to advance our psychedelic drug programs through clinical trials.”.

Research and Development 104

Research and Development Clinical Trials Therapy Environment 104

MMJ Recs

MARCH 6, 2024

Discover how legalization and regulation have influenced access and usage, and learn about the latest research and medical applications. Legalization and Regulation of Medical Marijuana The journey of legalizing and regulating medical marijuana in the US reflects a nuanced interplay of federal and state policies.

Marijuana 52

Marijuana Chronic Pain Patients Treatment 52

Cannabis Law Report

JULY 21, 2022

COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced that it has appointed Kabir Nath as Chief Executive Officer, effective August 1, 2022. London, UK July 19, 2022.

Therapy 52

Therapy Research and Development Pharmaceutical Patients 52

Cannabis Law Report

SEPTEMBER 28, 2021

The TGA has approved the use of MDMA and Psilocybin to treat mental illness in Australia by qualified medical professionals under a special access scheme. However, existing ACT legislation would need to be amended to allow this to proceed in the ACT,” said Ms Ollson. Here’s the details on the research project.

Therapy 52

Therapy Medicine Data Collective 52

Cannabis Law Report

APRIL 21, 2022

Commercialization & Patient Access · Any City, Any State, California. MAPS PBC is pioneering new forms of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for post-traumatic stress disorder (PTSD). About MAPS Public Benefit Corporation (MAPS PBC). Executive Summary.

Advocacy 52

Advocacy Therapy Clinical Trials Environment 52

Cannabis Law Report

JUNE 20, 2021

The CIC consists of 97 members dedicated to ensuring a greater understanding of the role of medicinal cannabis, nutraceutical CBD, and hemp across the community and the advancement of medicinal cannabis as an alternate line of therapy. Patient access.

Supply Chain 105

Supply Chain Clinical Trials Research and Development Medicine 105

Veriheal

OCTOBER 20, 2021

Veriheal does not support illegally consuming alternative therapeutic substances but acknowledges that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. Always consult a physician before attempting psychedelic therapy. A Magical Future.

Therapy 98

Therapy Microdosing Decriminalization Consumption 98

NORML

JANUARY 11, 2019

Legislation is pending, House Bill 1272, to expand access to medical cannabis in North Dakota. Legislation is pending, House Bill 366, to permit physicians to recommend cannabis therapy to those struggling with opioid addiction, misuse, or abuse. Legislation is pending, House Bill 350, to expand medical cannabis access.

Legislation 195

Legislation Decriminalization Hemp Patients 195

Cannabis Law Report

JULY 29, 2021

Pouya Farmand, CEO of Levitee, states: “We are thrilled to have acquired these five addiction clinics, which directly interface with patients that need alternative medicines and therapies the most. Recovery is the focus of ACT Medical’s policies and practices. About Levitee Labs . www.leviteelabs.com.

Chronic Pain 105

Chronic Pain Treatment Therapy Patients 105

Cannabis Law Report

MAY 26, 2022

The OPEN Foundation invites you to the Interdisciplinary Conference on Psychedelic Research this September, featuring the world’s best experts on psychedelic science and therapy. ICPR 2022 will feature over a hundred experts from psychiatry, healthcare policy, neuroscience, the humanities, and pharmacology.

Research and Development 52

Research and Development Therapy Policy Media 52

Cannabis Law Report

JUNE 19, 2022

The Psychedelic Access and Research European Alliance (PAREA) is a group founded in 2022 and comprised of 15 organizations with common goals in the field of mental health and psychedelics. We are equally excited about the inaugural launch of the Psychedelic Access and Research European Alliance! Opening keynote address : Prof.

Therapy 52

Therapy Advocacy Events Treatment 52

NORML

FEBRUARY 1, 2019

At the state level, activists in Florida and Missouri gathered in their state capitals along side state and local NORML chapters to lobby state lawmakers in favor of sensible marijuana policy reform. Click here to email your lawmakers in support of banking access. John Fetterman, Lt. CA resident? CT resident? Update : S. FL resident?

Legislation 165

Legislation Decriminalization Access Patients 165

The Cannigma

JUNE 2, 2023

The possession, use, and trafficking of cannabis are illegal, and the country maintains a zero-tolerance policy towards drugs. The use of cannabis for medicinal purposes is not permitted, and there are no legal avenues for patients to access cannabis-based medications.

Law 52

Law Research and Development Consumption Therapy 52

NORML

JANUARY 18, 2019

At the state level, patients in Ohio and Oklahoma now have access to medical cannabis, as sales began in both states this week. A medical cannabis access bill was signed into law in the U.S. If passed, this bill provides registered patients with regulated access to medical cannabis via licensed providers. NE resident?

Legislation 164

Legislation Decriminalization Access Therapy 164

NORML

MARCH 14, 2020

Veteran Access : HR 1647, the Veterans Equal Access Act, would allow V.A. Legislation is pending, Senate Bill 165, to establish a medical marijuana access program for qualified patients with a physician’s recommendation to access medical marijuana from licensed retail outlets. Your Highness, Carly. Actions to Take.

Legislation 189

Legislation Access Patients THC 189

Cannabis Law Report

JUNE 24, 2022

Scutari’s proposed “Psilocybin Behavioral Health Access and Services Act” represents a bold development in the psychedelics reform movement that’s rapidly spread in state legislatures and through citizen-led initiatives throughout the country in recent years. Full story at.

Clinical Trials 52

Clinical Trials Legalization Research and Development Therapy 52

Cannabis Law Report

DECEMBER 1, 2021

As psychedelic medicine becomes more mainstream, we must ensure that all who participate in healing therapeutic sessions, both above ground and in ceremonial or underground therapeutic settings, are safe and accessible to all. Emma teaches classes on integrating kink-based consent practices into psychedelic-assisted therapy.

Safety 52

Safety Medicine Therapy Research and Development 52

Cannabis Law Report

AUGUST 27, 2021

We offer evidence that the primary driver of these reductions is an improvement in work capacity, likely due to access to an additional form of pain management therapy. We estimate complementary declines in non-traumatic workplace injury rates and the incidence of worklimiting disabilities. Keshar M.

Therapy 105

Therapy Marijuana Legalization Access 105

Cannabis Law Report

APRIL 12, 2019

I am also prescribed pharmacological and non-pharmacological therapies and try to keep a base of exercise and good nutrition. CFAMM’s goal is to support medical cannabis patients, improve their outcomes and enable them to obtain fair and safe access to their medication. Canadian’s for Fair Access to Medical Marijuana .

Access 45

Access Patients Marijuana Medicine 45

Cannabis Law Report

MAY 18, 2022

With few solutions in sight, there is a growing body of evidence that suggests that psychedelic-assisted therapy could provide a breakthrough in treating countless mental health ailments, such as depression, substance abuse disorders, and PTSD. The clinical evidence for psychedelic assisted therapy is accumulating.

Research and Development 52

Research and Development Therapy Treatment Policy 52

Veriheal

AUGUST 11, 2023

In a significant move towards drug policy reform, Colorado Governor Jared Polis asked lawmakers for permission to grant pardons for individuals with certain psychedelic drug-related convictions. ” In addition, he stated that he looks forward to a time when people will no longer have to go to Columbia or Mexico for psychedelics therapy.

Decriminalization 90

Decriminalization Treatment Therapy Policy 90

Veriheal

AUGUST 24, 2022

This campaign was backed by New Approach PAC, a nationwide political organization that is focused on supporting progressive reform surrounding cannabis and criminal justice policies. In May 2022, Connecticut’s governor signed a budget bill that included a provision for the implementation of psychedelic-assisted therapy treatment centers.

Legalization 109

Legalization Decriminalization Medicine Research and Development 109

Cannabis Law Report

MARCH 29, 2022

We are thrilled to have Michael’s expertise guiding the development of MDMA-assisted therapy for PTSD! Former Moderna Vice President and Managing Director for North America recruited to prepare MAPS PBC for patient access and commercialization of the first psychedelic-assisted therapy anticipated to be approved by the FDA.

Therapy 52

Therapy Pharmaceutical Clinical Trials Access 52

Cannabis Law Report

MAY 25, 2022

May 25, 2022 – SACRAMENTO – Senator Scott Wiener (D-San Francisco)’s Senate Bill 1186 , which restores voter-created access to medicinal cannabis across the state by requiring cities to provide patients access to purchase medicinal cannabis by delivery, passed the Senate with a unanimous bipartisan vote. 20210SB1186_96.

Medicine 52

Medicine Legislation Chronic Pain Access 52

Veriheal

MARCH 11, 2022

veterans have called on the government to increase cannabis access, and Colorado police report a rise in street cannabis tainted with fentanyl. While the VSOs’ cannabis-centric request touched on a number of different ideas, most centered on how much veterans could stand to benefit from increased access to marijuana therapy.

CBD 69

CBD Access Cannabis Therapy 69